Palvella receives European patent for QTORIN rapamycin formulation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. SPY
2. DLR
3. EOSE
4. MU
5. AVAV
6. VSH
7. ENPH
8. BAC
9. NVDA
10. ABVX

Go back to Palvella receives European patent for QTORIN rapamycin formulation
(NASDAQ: PVLA) Delayed: 150.49 -4.35 (2.81%)
Previous Close $154.84    52 Week High $ 
Open $154.15    52 Week Low $ 
Day High $161.38    P/E N/A 
Day Low $147.47    EPS $ 
Volume 153,432